Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

eFFECTOR Therapeutics Inc. (EFTR)

  • Technical Exchange News
  • May 23, 2024, 19:00 UTC
  • 27
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

eFFECTOR Therapeutics Inc. (EFTRW)

  • Technical Exchange News
  • May 23, 2024, 19:00 UTC
  • 27
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Applied DNA Sciences Inc. (APDN)

  • Technical Exchange News
  • May 23, 2024, 19:00 UTC
  • 27
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Achilles Therapeutics plc (ACHL)

  • Technical Exchange News
  • May 23, 2024, 19:00 UTC
  • 29
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

P3 Health Partners Inc (PIII)

  • Technical Exchange News
  • May 23, 2024, 01:53 UTC
  • 29
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Petros Pharmaceuticals Inc. (PTPI)

  • Technical Exchange News
  • May 23, 2024, 01:53 UTC
  • 31
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Petros Pharmaceuticals Inc. (PTPI)

  • Technical Exchange News
  • May 22, 2024, 18:51 UTC
  • 35
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

P3 Health Partners Inc (PIII)

  • Technical Exchange News
  • May 22, 2024, 18:51 UTC
  • 34
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Enveric Biosciences Inc. (ENVB)

  • Technical Exchange News
  • May 22, 2024, 01:58 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Cingulate Inc. (CINGW)

  • Technical Exchange News
  • May 22, 2024, 01:58 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 586
  • 587
  • 588
  • 589
  • 590
  • Next

Search

News categories

  • Technical Exchange News(10945)
  • Event(2382)
  • SEC News(191987)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125306)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin